Valneva SE

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

12 5月 2025 01:00:00 条件 Nasdaq GlobeNewswire

VALNEVA Declaration of shares and voting rights: April 30, 2025

07 5月 2025 12:00:00 条件 Nasdaq GlobeNewswire

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

07 5月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

07 5月 2025 01:00:13 条件 Nasdaq GlobeNewswire

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

26 4月 2025 13:10:00 条件 Nasdaq GlobeNewswire

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

18 4月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

16 4月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva Receives First Marketing Authorization for IXCHIQ® in a Chikungunya Endemic Country

14 4月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva and LimmaTech Announce First Vaccination in Phase 2 Infant Study of Tetravalent Shigella Vaccine Candidate S4V2

09 4月 2025 01:00:00 条件 Nasdaq GlobeNewswire

Valneva SE Shareholding Declaration - March 2025

03 4月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above

01 4月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

31 3月 2025 01:00:00 条件 Nasdaq GlobeNewswire

Valneva Renews its Sales Agreement in connection with its Existing At-the-Market (ATM) Program

26 3月 2025 13:00:00 条件 Nasdaq GlobeNewswire

Valneva Announces Filing of 2024 Universal Registration Document and US Form 20-F

25 3月 2025 02:00:00 条件 Nasdaq GlobeNewswire

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

24 3月 2025 02:00:00 条件 Nasdaq GlobeNewswire

Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook

20 3月 2025 02:00:00 条件 Nasdaq GlobeNewswire

VALNEVA Declaration of shares and voting rights: February 28, 2025

05 3月 2025 12:00:00 条件 Nasdaq GlobeNewswire

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

03 3月 2025 01:00:00 条件 Nasdaq GlobeNewswire

Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

28 2月 2025 11:45:00 条件 Nasdaq GlobeNewswire

Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

18 2月 2025 01:00:00 条件 Nasdaq GlobeNewswire